GlassScriptPhysician profile
Nathan A Yeh
NPI 1942747464
$4,317.25
in general payments reported to CMS, 2019-2025
45 companies · $81.56 in 2025
The $81.56 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $724 · 2022: $2,734 · 2023: $433 · 2024: $345 · 2025: $81.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $821.03 | 2021-2025 | |
| Ucb, INC. | $266.62 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $227.96 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $226.71 | 2022 | |
| Sk Life Science, INC. | $171.50 | 2021-2022 | |
| Abbott Laboratories | $149.03 | 2021-2024 | Freestyle Libre 3 |
| Genentech USA, INC. | $146.08 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $139.32 | 2021-2023 | Austedo |
| Eisai INC. | $135.70 | 2022-2023 | |
| Amgen INC. | $122.34 | 2021-2022 | |
| Argenx US, INC. | $120.81 | 2022-2023 | Vyvgart |
| Ipsen Biopharmaceuticals, INC | $118.54 | 2021-2022 | |
| Biogen, INC. | $117.41 | 2021-2022 | |
| Lilly USA, LLC | $112.21 | 2022-2023 | Emgality, Reyvow |
| Avion Pharmaceuticals | $101.67 | 2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Yeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.